UBS Group AG Notifies Participation: A Significant Update for Investors

UBS Group AG Discloses Transparency Notification to Solvay Brussels, September 27, 2024, 08:30 CEST – Regulated Information In line with Belgian transparency legislation (Law of May 2, 2007), UBS Group AG recently sent to Solvay the following transparency notification indicating that they crossed the threshold of 3%. The notification, dated September 24, 2024, contains the…

Read More

Breaking News: Cue Biopharma Sets Record with $12.0 Million Public Offering

Cue Biopharma Announces Public Offering of Common Stock September 26, 2024 Boston, MA Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company specializing in therapeutic biologics, has announced the pricing of an underwritten public offering of common stock. The offering includes 11,564,401 shares of common stock and accompanying common stock warrants, as well as pre-funded…

Read More